On November tenth, a federal judge temporarily halted Oklahomas new law aimed at boosting hospital profits by regulating discounted drug acquisition. The law, House Bill two thousand forty-eight, was designed to prevent drug manufacturers from interfering with hospitals buying medicine through the federal three forty-B drug pricing program. The program allows certain healthcare providers to buy drugs at a lower rate and sell them at full price, using the profits for operating costs. However, drug manufacturers started placing restrictions on these contracts, leading to significant revenue losses for many hospitals. The judges order means the law will remain on hold while the court decides if its constitutional, with Oklahomas Attorney General planning to appeal.

The Daily News Now! — Every city. Every story. AI-powered.

Hosted on Acast. See acast.com/privacy for more information.